Abstract
Ceftriaxone, third-generation cephalosporin, is widely used in patients for the treatment of serious gram-negative infection without a dose adjustment for renal insufficiency. Ceftriaxone-induced neurotoxicity, particularly non-convulsive status epilepticus (NCSE), has rarely been reported. We present a case of ceftriaxone-induced non-convulsive status epilepticus in treatment of complicated urinary tract infection and acute on chronic kidney disease (CKD) for a 71-year-old woman. The prognosis of NCSE is poor in elderly patients due to a delay in diagnosis and treatment may be associated with increased mortality or neuronal loss, as well as dysfunction of cognitive and behavioral abilities. Emergent and continuous electroencephalogram monitoring can assist physicians in both early recognition and accurate management of NCSE. Immediate withdrawal of cephalosporin is necessary. Antiepileptic drugs may be helpful but data of prognosis are still lacking. Physicians should be aware of the potential neurotoxic complication in those with high risks (elderly, CKD, or prior central nervous system conditions).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
